The brain response GLP-1 crosses the blood-brain barrier through passive diffusion and receptor-mediated transcytosis
The Business Group on Health survey found that among companies that cover GLP-1s for weight management, 10% are unlikely or very unlikely to continue the coverage in 2027 for cost reasons, according to Magda Rusinowski, vice president of the non-profit, which represents employers' perspectives on health-related issues
Commissioner Makary stated: "Compounded drugs can be important for overcoming shortages or meeting unique patient needs, but compounders should not try to compound drugs in a way that circumvents FDA's approval process." While these targeted injectables, not herbal patches, the regulatory direction is clear
Resistance training becomes particularly important to preserve muscle mass during rapid weight loss
Whilst Phase 2 data show a compelling efficacy signal, the drug remains unlicensed in the UK by the MHRA
General estimates of stability (such as "up to 28 days") are not validated for retatrutide and should not be applied without product-specific evidence
